Staar Surgical announced the EVO ICL Clinical Program, which will be presented by ophthalmic surgeons to ophthalmic surgeons at its invitation only Surgical Experts Summit, is expected to be attended by over 250 surgeons and invited clinician guests from 46 countries. The Experts Summit will be held in Paris, France, directly ahead of the European Society of Cataract and Refractive Surgeons Meeting (ESCRS). Thirty-one surgeons will present clinical data and moderate presentations, panels and roundtable sessions on the EVO Visian ICL and refractive surgery topics. The following is a representative selection from the myriad clinical topics to be addressed during the Experts Summit:
- My Paradigm Shifts in Refractive Surgery: Why I moved to an ICL Only Practice
- EVO Visian ICL for Myopes over 45 Years: Clinical Outcomes
- Immediate Bilateral EVO Surgery Protocol
- Improving Optics in Challenging Corneas
- Best Screening for Keratoconus & EVO Visian ICL Application
- EVO Visian ICL and SMILE in Low-to-Moderate Diopter Patient
- Over 20 years of EVO Visian ICL in My Patient’s Eyes
- Key Clinical Drivers for EVO Visian ICL Indications
- Developing a Consensus Group Approach in China – Relevance and Future Outlook.
Following the Experts Summit, Staar will exhibit at the ESCRS in Paris at Pavilion 7, Paris Expo Porto de Versailles, Booth Number E101 from Saturday, September 14, through Wednesday, September 18. Staar will host pre-certification surgeon training courses, roundtables and education sessions, including digital marketing and patient education tutorials. At this time, Staar is expecting over 50 talks at the Congress where Staar is presented alone or in combination with other refractive surgical options.
“Our Experts Summit and ESCRS are among our largest and most important customer events each year. We wish to thank in advance all the global refractive surgeon experts who are dedicated to making the ICL the premium and primary refractive procedure for vision correction,” Caren Mason, President & CEO of Staar Surgical, said in a company news release.